Blueprint
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of
1934
|
Date of
Report (Date of earliest event reported)
|
November 15, 2018
|
|
|
|
SANUWAVE HEALTH, INC.
|
|
(Exact
name of registrant as specified in its charter)
|
|
Nevada
|
000-52985
|
20-1176000
|
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
|
3360 Martin Farm Road, Suite 100, Suwanee, Georgia
|
30024
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
Registrant’s
telephone number, including area code
|
(770) 419-7525
|
|
N/A
|
|
(Former
name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registration is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 or
Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging
growth company. ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item
2.02
Results of Operations and Financial Condition.
On
November 15, 2018, SANUWAVE Health, Inc., a Nevada Corporation (the
"Company"), announced its product revenue for the three months
ended September 30, 2018 and provided a business update via
conference call. A copy of the related press release is furnished
as Exhibit 99.1 to
this Form 8-K. A copy of the transcript of such call is furnished
as Exhibit 99.2 to
this Form 8-K.
The
information in this Item 2.02 of this Current Report on Form 8-K
and the exhibits attached hereto shall not be deemed to be "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, and shall not be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, except as
shall be expressly set forth by specific reference in such
filing.
Item
9.01
Financial
Statements and Exhibits.
Press release,
dated November 15, 2018, issued by SANUWAVE Health, Inc., titled
“SANUWAVE Health reports strong third quarter
revenue.”
Transcript of the
November 15, 2018, SANUWAVE Health, Inc. conference call to discuss
third quarter 2018 and provide a business update.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
SANUWAVE
HEALTH, INC.
|
|
|
|
|
|
|
|
Dated: November 20,
2018
|
By:
|
/s/
Lisa E. Sundstrom
|
|
|
|
Name:
|
Lisa E.
Sundstrom
|
|
|
|
Title:
|
Controller and
Chief Financial Officer
|
|